Central Nervous System Side Effects of Ganciclovir
- 29 March 1990
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (13) , 933-934
- https://doi.org/10.1056/nejm199003293221315
Abstract
Ganciclovir is proving to be effective therapy in patients who have cytomegalovirus (CMV) disease.1 2 3 The only exceptions are recipients of bone marrow transplants and patients with the acquired immunodeficiency syndrome (AIDS) who have CMV pneumonitis.4 5 6 The drug's most frequent side effects are neutropenia and thrombocytopenia.6 , 7 Laskin and Drew and their colleagues also noted changes in mental status in patients with AIDS. We now report central nervous system toxicity in a renal-transplant recipient.Keywords
This publication has 8 references indexed in Scilit:
- Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow TransplantsAnnals of Internal Medicine, 1988
- GANCICLOVIR THERAPY OF SEVERE CYTOMEGALOVIRUS INFECTIONS IN SOLID-ORGAN TRANSPLANT RECIPIENTSTransplantation, 1988
- Herpesvirus Infections (Cytomegalovirus, Herpes Simplex Virus, Varicella-Zoster Virus)Infectious Disease Clinics of North America, 1988
- CYCLOSPORINE PLASMA LEVELS SIX HOURS AFTER ORAL ADMINISTRATIONTransplantation, 1988
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirusThe American Journal of Medicine, 1987
- Treatment of Cytomegalovirus Pneumonia with 9-[2-Hydroxy-1-(Hydroxymethyl) ethoxymethyl] Guanine and High-Dose CorticosteroidsAnnals of Internal Medicine, 1986
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986